REGISTERED NUMBER: 08162052 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 July 2025

for

Onyx Medico Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Dr O Makki

Dr T Makki

SECRETARY:

Dr T Makki

REGISTERED OFFICE:

117-119 Cleethorpe Road

Grimsby

North East Lincs

DN31 3ET

REGISTERED NUMBER:

08162052 (England and Wales)

FIXED ASSETS

Tangible assets

4

6,716

4,988

CURRENT ASSETS

Debtors

5

6,510

5,957

Cash at bank

3,437

24,680

9,947

30,637

CREDITORS

Amounts falling due within one year

6

14,126

37,439

NET CURRENT LIABILITIES

(4,179

)

(6,802

)

TOTAL ASSETS LESS CURRENT LIABILITIES

2,537

(1,814

)

CAPITAL AND RESERVES

Called up share capital

4

3

Retained earnings

2,533

(1,817

)

2,537

(1,814

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 May 2026 and were signed on its behalf by:

Dr O Makki - Director

1.	STATUTORY INFORMATION

Onyx Medico Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost and 20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern

The directors confirms that all external creditors will be satisfied and they will continue to provide their financial support.

Based on this fact, the directors are aware on any reason to suggest that the company should not be able to finance its operations and other obligations for a period of at least twelve months from the date of approval of these financial statements and therefore to prepare the financial statements on a going concern basis.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 August 2024

15,481

Additions

4,392

Disposals

(678

)

At 31 July 2025

19,195

DEPRECIATION

At 1 August 2024

10,493

Charge for year

2,269

Eliminated on disposal

(283

)

At 31 July 2025

12,479

NET BOOK VALUE

At 31 July 2025

6,716

At 31 July 2024

4,988

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.7.25

31.7.24

£

£

Other debtors

6,510

5,957

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.7.25

31.7.24

£

£

Bank loans and overdrafts

-

2,250

Other creditors

14,126

35,189

14,126

37,439

7.	LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

31.7.25

31.7.24

£

£

Within one year

5,549

6,785

Between one and five years

-

5,088

5,549

11,873